Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company dedicated to the prevention and treatment of ...
NDAQ:ATOS) Atossa Therapeutics Issues Letter to Shareholders Highlighting 2024 Accomplishments and Outlook for 2025 ...
The true incidence of thrombosis among people who received targeted therapy for breast cancer is significantly higher than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback